BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: El-Sahli S, Wang L. Cancer Stem Cell-Associated Pathways in the Metabolic Reprogramming of Breast Cancer. Int J Mol Sci 2020;21:E9125. [PMID: 33266219 DOI: 10.3390/ijms21239125] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Luo S, Jiang Y, Anfu Zheng, Zhao Y, Wu X, Li M, Du F, Chen Y, Deng S, Chen M, Li W, Li X, Gu L, Sun Y, Xiao Z, Shen J. Targeting hypoxia-inducible factors for breast cancer therapy: A narrative review. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1064661] [Reference Citation Analysis]
2 Pan C, Cong A, Ni Q. Microarray data reveal potential genes that regulate triple-negative breast cancer. J Int Med Res 2022;50:3000605221130188. [PMID: 36238993 DOI: 10.1177/03000605221130188] [Reference Citation Analysis]
3 Jovanović Galović A, Jovanović Lješković N, Vidović S, Vladić J, Jojić N, Ilić M, Srdić Rajić T, Kojić V, Jakimov D. The Effects of Resveratrol-Rich Extracts of Vitis vinifera Pruning Waste on HeLa, MCF-7 and MRC-5 Cells: Apoptosis, Autophagia and Necrosis Interplay. Pharmaceutics 2022;14:2017. [DOI: 10.3390/pharmaceutics14102017] [Reference Citation Analysis]
4 Liu J, Nie C. KDM5B regulates the PTEN/PI3K/Akt pathway to increase sorafenib-resistance in hepatocellular carcinoma. Anticancer Drugs 2022. [PMID: 35946516 DOI: 10.1097/CAD.0000000000001329] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Gutierrez-cruz JA, Maldonado V, Melendez-zajgla J. Regulation of the Cancer Stem Phenotype by Long Non-Coding RNAs. Cells 2022;11:2352. [DOI: 10.3390/cells11152352] [Reference Citation Analysis]
6 Saha T, Lukong KE. Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance. Front Oncol 2022;12:856974. [PMID: 35392236 DOI: 10.3389/fonc.2022.856974] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
7 Sun M, Liu X, Zhao W, Zhang B, Deng P. Circ_0058063 contributes to cisplatin-resistance of bladder cancer cells by upregulating B2M through acting as RNA sponges for miR-335-5p. BMC Cancer 2022;22:313. [PMID: 35321689 DOI: 10.1186/s12885-022-09419-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Liu Y, Ma L, Hua F, Min Z, Zhan Y, Zhang W, Yao J. Exosomal circCARM1 from spheroids reprograms cell metabolism by regulating PFKFB2 in breast cancer. Oncogene 2022. [PMID: 35027669 DOI: 10.1038/s41388-021-02061-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Tang L, Xiao Q, Mei Y, He S, Zhang Z, Wang R, Wang W. Insights on functionalized carbon nanotubes for cancer theranostics. J Nanobiotechnology 2021;19:423. [PMID: 34915901 DOI: 10.1186/s12951-021-01174-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
10 Ershov P, Kaluzhskiy L, Mezentsev Y, Yablokov E, Gnedenko O, Ivanov A. Enzymes in the Cholesterol Synthesis Pathway: Interactomics in the Cancer Context. Biomedicines 2021;9:895. [PMID: 34440098 DOI: 10.3390/biomedicines9080895] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Shen YA, Chen CC, Chen BJ, Wu YT, Juan JR, Chen LY, Teng YC, Wei YH. Potential Therapies Targeting Metabolic Pathways in Cancer Stem Cells. Cells 2021;10:1772. [PMID: 34359941 DOI: 10.3390/cells10071772] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
12 Shen Y, Chen C, Chen B, Wu Y, Juan J, Chen L, Teng Y, Wei Y. Potential Therapies Targeting Metabolic Pathways in Cancer Stem Cells. Cells 2021;10:1772. [DOI: 10.3390/cells10071772] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Zhang H, Steed A, Co M, Chen X. Cancer stem cells, epithelial-mesenchymal transition, ATP and their roles in drug resistance in cancer. Cancer Drug Resist 2021;4:684-709. [PMID: 34322664 DOI: 10.20517/cdr.2021.32] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]